Inhibitors of fatty acid amide hydrolase reduce carrageenan‐induced hind paw inflammation in pentobarbital‐treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors
10.1038/sj.bjp.0706348
Crossref journal-article
Wiley
British Journal of Pharmacology (311)
Abstract

The in vivo effect of inhibitors of fatty acid amide hydrolase (FAAH) upon oedema volume and FAAH activity was evaluated in the carrageenan induced hind paw inflammation model in the mouse. Oedema was measured at two time points, 2 and 4 h, after intraplantar injection of carrageenan to anaesthetised mice. Intraperitoneal (i.p.) injections of the FAAH inhibitor URB597 (0.1, 0.3, 1 and 3 mg kg−1) 30 min prior to carrageenan administration, dose‐dependently reduced oedema formation. At the 4 h time point, the ED50 for URB597 was ∼0.3 mg kg−1. Indomethacin (5 mg kg−1 i.p.) completely prevented the oedema response to carrageenan. The antioedema effects of indomethacin and URB597 were blocked by 3 mg kg−1 i.p. of the CB2 receptor antagonist SR144528. The effect of URB597 was not affected by pretreatment with the peroxisome proliferator‐activated receptor γ antagonist bisphenol A diglycidyl ether (30 mg kg−1 i.p.) or the TRPV1 antagonist capsazepine (10 mg kg−1 i.p.), when oedema was assessed 4 h after carrageenan administration. The CB1 receptor antagonists AM251 (3 mg kg−1 i.p.) and rimonabant (0.5 mg kg−1 i.p.) gave inconsistent effects upon the antioedema effect of URB597. FAAH measurements were conducted ex vivo in the paws, spinal cords and brains of the mice. The activities of FAAH in the paws and spinal cords of the inflamed vehicle‐treated mice were significantly lower than the corresponding activities in the noninflamed mice. PMSF treatment almost completely inhibited the FAAH activity in all three tissues, as did the highest dose of URB597 (3 mg kg−1) in spinal cord samples, whereas no obvious changes were seen ex vivo for the other treatments. In conclusion, the results show that in mice, treatment with indomethacin and URB597 produce SR144528‐sensitive anti‐inflammatory effects in the carrageenan model of acute inflammation. British Journal of Pharmacology (2005) 146, 467–476. doi:10.1038/sj.bjp.0706348

Bibliography

Holt, S., Comelli, F., Costa, B., & Fowler, C. J. (2005). Inhibitors of fatty acid amide hydrolase reduce carrageenan‐induced hind paw inflammation in pentobarbital‐treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors. British Journal of Pharmacology, 146(3), 467–476. Portico.

Authors 4
  1. Sandra Holt (first)
  2. Francesca Comelli (additional)
  3. Barbara Costa (additional)
  4. Christopher J Fowler (additional)
References 62 Referenced 141
  1. 10.1046/j.1460-9568.2003.02470.x
  2. 10.1002/jms.729
  3. 10.1152/ajpheart.00184.2004
  4. 10.1046/j.1471-4159.2003.02244.x
  5. 10.1016/S0014-2999(00)00226-0
  6. 10.1096/fj.04-1754fje
  7. 10.1096/fj.02-1075fje / FASEB J. / PPARγ ligands induce prostaglandin production in vascular smooth muscle cells: indomethacin acts as a peroxisome proliferator‐activated receptor‐γ antagonist by BISHOP‐BAILEY D. (2003)
  8. 10.1016/j.pbb.2005.01.027
  9. 10.1016/j.jbbm.2004.04.020
  10. 10.1016/S0304-3959(01)00454-7
  11. {'key': 'e_1_2_7_12_1', 'first-page': '1138', 'article-title': 'The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity', 'volume': '283', 'author': 'COMPTON D.R.', 'year': '1997', 'journal-title': 'J. Pharmacol. Exp. Ther.'} / J. Pharmacol. Exp. Ther. / The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity by COMPTON D.R. (1997)
  12. 10.1038/sj.bjp.0704466
  13. 10.1038/sj.bjp.0705920
  14. 10.1073/pnas.0401292101
  15. 10.1038/sj.bjp.0705412
  16. 10.2165/00023210-200317030-00004
  17. 10.1016/j.ejphar.2003.10.056
  18. 10.1016/S0006-8993(02)04056-8
  19. 10.1016/0006-2952(93)90486-G
  20. {'key': 'e_1_2_7_21_1', 'first-page': '605', 'article-title': 'Determination and characterization of a cannabinoid receptor in rat brain', 'volume': '34', 'author': 'DEVANE W.A.', 'year': '1988', 'journal-title': 'Mol. Pharmacol.'} / Mol. Pharmacol. / Determination and characterization of a cannabinoid receptor in rat brain by DEVANE W.A. (1988)
  21. 10.1042/bj3310015
  22. 10.1016/S0014-2999(00)00687-7
  23. 10.1124/jpet.104.078980
  24. 10.1038/sj.bjp.0704565
  25. 10.2174/1568015043356968
  26. 10.1080/1475636021000049726
  27. 10.1016/S0014-5793(97)01603-7
  28. 10.1523/JNEUROSCI.22-16-06900.2002
  29. 10.1016/S0014-2999(02)02485-8
  30. {'key': 'e_1_2_7_31_1', 'first-page': '51', 'article-title': 'FAAH inhibitors and indomethacin reduce carrageenan induced hind paw inflammation in the mouse – role of cannabinoid receptors. 2004 Symposium on the Cannabinoids, Burlington, Vermont', 'author': 'HOLT S.', 'year': '2004', 'journal-title': 'Int Cannabinoid Res Soc'} / Int Cannabinoid Res Soc / FAAH inhibitors and indomethacin reduce carrageenan induced hind paw inflammation in the mouse – role of cannabinoid receptors. 2004 Symposium on the Cannabinoids, Burlington, Vermont by HOLT S. (2004)
  31. 10.1016/j.lfs.2004.09.005
  32. 10.1074/jbc.M107351200
  33. 10.1016/S0024-3205(01)01374-1
  34. {'key': 'e_1_2_7_35_1', 'first-page': '420', 'article-title': 'In vitro and in vivo pharmacological characterization of JTE‐907, a novel selective ligand for cannabinoid CB2 receptor', 'volume': '296', 'author': 'IWAMURA H.', 'year': '2001', 'journal-title': 'J. Pharmacol. Exp. Ther.'} / J. Pharmacol. Exp. Ther. / In vitro and in vivo pharmacological characterization of JTE‐907, a novel selective ligand for cannabinoid CB2 receptor by IWAMURA H. (2001)
  35. 10.1038/sj.bjp.0704293
  36. 10.1124/mol.66.2.204
  37. 10.1038/nm803
  38. 10.1016/S0304-3959(02)00450-5
  39. 10.1021/jm058183t
  40. 10.1074/jbc.272.6.3406
  41. 10.1124/jpet.104.069401
  42. 10.1016/j.pain.2004.01.022
  43. 10.1124/mol.104.006353 / Mol. Pharmacol. / The nuclear receptor PPAR‐α mediates the antiinflammatory actions of palmitoylethanolamide by LO VERME J. (2005)
  44. 10.1172/JCI200419465
  45. 10.1021/jm031140x
  46. 10.1038/365061a0
  47. 10.1111/j.1471-4159.1984.tb12750.x
  48. 10.1002/(SICI)1098-2795(199610)45:2<183::AID-MRD11>3.0.CO;2-2
  49. 10.1016/S0163-7258(02)00255-3
  50. 10.1084/jem.184.3.883
  51. 10.1097/00000542-200310000-00031
  52. 10.1006/taap.2001.9342
  53. 10.1054/plef.2001.0362
  54. {'key': 'e_1_2_7_55_1', 'first-page': '644', 'article-title': 'SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor', 'volume': '284', 'author': 'RINALDI‐CARMONA M.', 'year': '1998', 'journal-title': 'J. Pharmacol. Exp. Ther.'} / J. Pharmacol. Exp. Ther. / SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor by RINALDI‐CARMONA M. (1998)
  55. 10.1016/S1043-6618(03)00188-9
  56. 10.1016/S0028-3908(03)00195-3
  57. 10.1023/A:1015500531113
  58. 10.1016/S0016-5085(98)70370-1
  59. 10.1124/jpet.103.064154
  60. {'key': 'e_1_2_7_61_1', 'article-title': 'The FAAH inhibitor URB597 reverses inflammatory pain through a CB1 receptor mediated mechanism', 'author': 'WILSON A.W.', 'year': '2005', 'journal-title': 'Proc. Br. Pharm. Soc.'} / Proc. Br. Pharm. Soc. / The FAAH inhibitor URB597 reverses inflammatory pain through a CB1 receptor mediated mechanism by WILSON A.W. (2005)
  61. 10.1074/jbc.272.34.21181
  62. 10.1038/22761
Dates
Type When
Created 20 years ago (Aug. 15, 2005, 12:41 a.m.)
Deposited 1 year, 10 months ago (Oct. 15, 2023, 6:53 a.m.)
Indexed 1 month ago (Aug. 2, 2025, 1:05 a.m.)
Issued 19 years, 11 months ago (Oct. 1, 2005)
Published 19 years, 11 months ago (Oct. 1, 2005)
Published Online 16 years, 7 months ago (Jan. 29, 2009)
Published Print 19 years, 11 months ago (Oct. 1, 2005)
Funders 0

None

@article{Holt_2005, title={Inhibitors of fatty acid amide hydrolase reduce carrageenan‐induced hind paw inflammation in pentobarbital‐treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors}, volume={146}, ISSN={1476-5381}, url={http://dx.doi.org/10.1038/sj.bjp.0706348}, DOI={10.1038/sj.bjp.0706348}, number={3}, journal={British Journal of Pharmacology}, publisher={Wiley}, author={Holt, Sandra and Comelli, Francesca and Costa, Barbara and Fowler, Christopher J}, year={2005}, month=oct, pages={467–476} }